文献速递儿童青少年精神

ADHD与ASD诊断相关特征随时间的变化

Changes in Characteristics Associated With ADHD and ASD Diagnoses Over Time.
PubMed 文献 · JAMA Psychiatry · 2026-09-09

这项基于丹麦全国登记数据的匹配病例对照研究纳入2012至2022年确诊的71 317例ADHD或ASD儿童青少年及713 170名对照,分析19项诊断前特征与诊断的关联随时间的变化。结果显示所有特征差异随时间缩小、OR向无效值衰减,ADHD比ASD更明显,10至17岁诊断者比低龄诊断者更明显。提示诊断率上升可能反映诊断实践或医疗能力变化,而非仅潜在风险改变。

要点

  • ADHD与ASD诊断前特征差异随时间缩小,OR向无效值衰减。
  • 低出生体重OR从2012至2013年的1.54降至2020至2022年的1.17。
  • ADHD的OR年均变化大于ASD,社会经济与围产期因素衰减更明显。

核心结论

  • 2012至2022年确诊ADHD或ASD的儿童青少年与无诊断同龄人越来越相似。
  • 诊断率上升可能反映诊断实践或医疗能力变化,而非仅潜在风险改变。
  • 不应将此解读为ADHD或ASD在个体层面损害变轻的证据。

研究设计与样本

  • 基于丹麦全国登记数据的 population-based 匹配病例对照研究。
  • 纳入1994年1月1日至2022年12月31日出生、随访至18岁者。
  • 2012至2022年18岁前确诊ADHD或ASD者为病例,按性别、出生年、居住市镇和出生国1:10匹配对照。
  • 分析19项诊断前特征,含父母与家庭因素、出生与围产期因素及医疗服务使用。

主要发现

  • 登记库共2 194 951名儿童青少年,100 323人(4.6%)18岁前确诊ADHD或ASD。
  • 2012至2022年确诊的71 317例为病例(26 452名女性[37.1%];诊断中位年龄11.4[IQR 8.1至14.9]岁),匹配713 170名对照。
  • 病例与对照在所有特征上均有差异,但差异随时间缩小、OR向无效值衰减,社会经济与围产期因素尤明显。
  • 低出生体重OR从2012至2013年的1.54(95%CI 1.41至1.68)降至2020至2022年的1.17(95%CI 1.10至1.24)。
  • 衰减在ADHD大于ASD(家庭收入OR年均变化:ADHD 6.5%[95%CI 5.7%至7.3%],ASD 0.7%[95%CI -0.1%至1.5%]),10至17岁诊断者比低龄诊断者更明显。

关键数值与推荐

  • 关联以条件logistic回归估计的OR及95%CI表示。
  • 按诊断年份分析诊断前特征与ADHD或ASD诊断的关联。
  • 结果在不同性别及限于诊断确定性较高病例的分析中模式相似。

临床怎么用

  • 临床解读ADHD或ASD诊断率上升时,应考虑诊断实践与医疗能力变化。
  • 不应因诊断率上升而推断个体层面损害程度下降。
  • 评估风险因素时需注意其与诊断关联随时间减弱。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Diagnoses of attention-deficit/hyperactivity disorder (ADHD) and autism spectrum disorder (ASD) have increased substantially in recent decades, but it is unclear whether associations of prediagnostic characteristics with these diagnoses have changed over time. OBJECTIVE: To examine temporal trends in associations between well-defined risk factors and subsequent diagnoses of ADHD and ASD. DESIGN, SETTING, AND PARTICIPANTS: This population-based matched case-control study was conducted using nationwide Danish registry data for individuals born between January 1, 1994, and December 31, 2022, followed up to age 18 years. Individuals diagnosed with ADHD or ASD before age 18 years between 2012 and 2022 were included as cases. Each case was matched to 10 controls without these diagnoses by sex, birth year, municipality of residence, and country of birth. Data were analyzed from April 2025 through June 2026. EXPOSURE: A list of 19 prediagnostic characteristics, including parental and family factors, birth and perinatal factors, and health care use. MAIN OUTCOMES AND MEASURES: Associations between prediagnostic characteristics and ADHD or ASD diagnoses by year of diagnosis, estimated as odds ratios (ORs) with 95% CIs using conditional logistic regression. RESULTS: Of 2 194 951 children and adolescents in the registry, 100 323 individuals (4.6%) were diagnosed with ADHD or ASD before age 18 years, among whom 71 317 children and adolescents were diagnosed between 2012 and 2022 and included as cases (26 452 female [37.1%]; median [IQR] age at diagnosis, 11.4 [8.1 to 14.9] years), matched with 713 170 controls. Individuals diagnosed with ADHD or ASD differed from controls across all characteristics, but differences diminished over time, with ORs attenuating toward the null, particularly for socioeconomic and perinatal factors. For example, the OR for low birth weight decreased from 1.54 (95% CI, 1.41 to 1.68) in 2012 to 2013 to 1.17 (95% CI, 1.10 to 1.24) in 2020 to 2022. Attenuation was greater for ADHD than ASD (eg, household income: mean yearly change in OR, 6.5% [95% CI, 5.7% to 7.3%] for ADHD; mean yearly change in OR, 0.7% [95% C, -0.1% to 1.5%] for ASD) and more pronounced among individuals diagnosed at ages 10 to 17 years than at younger ages. Patterns were similar across sexes and in analyses restricted to cases with higher diagnostic certainty. CONCLUSIONS AND RELEVANCE: This study found that from 2012 to 2022, children and adolescents diagnosed with ADHD or ASD became increasingly similar to peers without these diagnoses. These findings suggest that increasing diagnostic rates may reflect changes in diagnostic practices or health care capacity rather than changes in underlying risk alone and should not be interpreted as evidence that ADHD or ASD have become less impairing at the individual level.

来源:JAMA Psychiatry,查看原文。版权归原作者所有。

引用

  1. Tarp ME, Lousdal ML, Rask CU, et al. Changes in Characteristics Associated With ADHD and ASD Diagnoses Over Time. JAMA Psychiatry. 2026. PMID: 42714883. doi:10.1001/jamapsychiatry.2026.2722

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。